2 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 2 |
Follow Allergic Rhinoconjunctivitis: new trials by email Literature Review of Allergic Rhinoconjunctivitis trials Research Report on Allergic Rhinoconjunctivitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/Rhinoconjunctivitis MM09 allergoid-mannan conjugates subcutaneous (3.000 UTm/mL), MM09 allergoid-mannan conjugates Sublingual (3.000 UTm/mL), MM09 allergoid-mannan conjugates Sublingual (9.000 UTm/mL) - House Dust Mite Allergy, Perennial Allergic Rhinitis | Phase 3 | Unknown | Inmunotek S.L. | 400 | 2022-12-01 | 2022-11-18 |
| A Randomised, Double-blind, Placebo Controlled Study With Oralgen Grass Pollen Rhinoconjunctivitis Oralgen, placebo control - Allergic Rhinoconjunctivitis | Phase 3 | Unknown | Artu Biologicals | 374 | 2008-12-01 | 2010-04-30 |
Hypersensitivity (2) · Dust Mite Allergy (1) · Rhinitis, Allergic, Perennial (1)
Immune System Diseases (2) · Hypersensitivity, Immediate (1) · Nose Diseases (1) · Otorhinolaryngologic Diseases (1) · Respiratory Hypersensitivity (1) · Respiratory Tract Diseases (1) · Rhinitis (1) · Rhinitis, Allergic (1)
grass pollen extract, alum-adsorbed (1)
Artu Biologicals (1) · Inmunotek S.L. (1)
Belgium (1) · France (1) · Germany (1) · Netherlands (1) · Poland (1) · Spain (1) · United Kingdom (1)